Identification of hepatitis C virus 2k/1b intergenotypic recombinants in Georgia.

Mamuka ZakalashviliJaba ZarkuaMichael WeizeneggerJan BartelMonika RaabeLela ZangurashviliNino KankiaNino JashiashviliMaka LomidzeTengiz TeliaVakhtang KerashviliMaia ZhamutashviliNikoloz AbramishviliCharlotte HedskogKrishna ChodavarapuDiana M BrainardJohn G McHutchisonHongmei MoEvguenia SvarovskaiaRobert G GishIrakli RtskhiladzeDavid Metreveli

Published in: Liver international : official journal of the International Association for the Study of the Liver (2017)

The 19.7% prevalence of RF1_2k/1b in Georgia patients is far higher than has generally been reported to date worldwide. Identification of recombinants in low income countries with a high prevalence of HCV infection might be reasonable for choosing the most cost-effective treatment regimens.

Keyphrases

hepatitis c virus
human immunodeficiency virus
end stage renal disease
ejection fraction
newly diagnosed
prognostic factors
bioinformatics analysis
patient reported outcomes
hiv infected